Stock Screener App

Frei -

Installieren

1.31

11.49% -0.17

Anavex Life Sciences Corp (AVXL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Anavex Life Sciences Corp-Aktie (AVXL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	203.90% -6.737	6.484	6.782	10.84	14.46
Operating Income/Loss	203.90% 6.737	-6.484	-6.782	-10.84	-14.46
Net Interest Income/Expense	1.04% 1.072	1.061	1.079	0.999	1.075
Nonoperating Income/Loss	5.15% 1.087	1.146	1.119	1.017	1.216
Income Tax Expense/Benefit	-	-	0.018	-	-
Net Income/Loss	246.57% 7.824	-5.338	-5.681	-9.827	-13.24
Basic Average Shares	99,923% 92,696.84	92.68	89.03	0.2037	85.38
Diluted Average Shares	100.14K% 92,899.54	92.68	89.03	0.2037	85.38
Basic Earnings Per Share	233.33% 0.08	-0.06	-0.06	-0.11	-0.16
Diluted Earnings Per Share	233.33% 0.08	-0.06	-0.06	-0.11	-0.16

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters